Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	BYM338 70 mg	19
Overall Study	STARTED	BYM338 210 mg	18
Overall Study	STARTED	BYM338 700 mg	113
Overall Study	STARTED	Placebo	67
Overall Study	COMPLETED	BYM338 70 mg	17
Overall Study	COMPLETED	BYM338 210 mg	12
Overall Study	COMPLETED	BYM338 700 mg	95
Overall Study	COMPLETED	Placebo	64
Overall Study	NOT COMPLETED	BYM338 70 mg	2
Overall Study	NOT COMPLETED	BYM338 210 mg	6
Overall Study	NOT COMPLETED	BYM338 700 mg	18
Overall Study	NOT COMPLETED	Placebo	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02333331/flow